Crossref
Phase 1 trials of PNPLA3 siRNA in I148M homozygous patients with MAFLD
Yearbook of Paediatric Endocrinology · 30.09.2025
DOI: 10.1530/ey.22.15.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von Fabbrini E und 27 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
E, F., B, R., A, K., JY, J., VS, A., C, G., N, D., S, W., J, H., H, H., ZM, D., M, A., A, N., T, P., M, N., S, O., Y, S., A, Y., R, T., …, & H, M. (2025). Phase 1 trials of PNPLA3 siRNA in I148M homozygous patients with MAFLD. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.15.2
Vancouver
E F, B R, A K, JY J, VS A, C G, et al. Phase 1 trials of PNPLA3 siRNA in I148M homozygous patients with MAFLD. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.15.2
BibTeX
@article{E2025,
author = {E, Fabbrini and B, Rady and A, Koshkina and JY, Jeon and VS, Ayyar and C, Gargano and N, DiProspero and S, Wendel and J, Hegge and H, Hamilton and ZM, Ding and M, Afrazi and A, Nicholas and T, Pei and M, Nakano and S, Ouchi and Y, Saito and A, Yamashita and R, Tamamura and H, Salazar and C, Shapiro and T, Yoshihara and T, Yonemura and S, Inoue and O, Matsuoka and M, Erion and A, Pocai and H, Makimura},
title = {Phase 1 trials of PNPLA3 siRNA in I148M homozygous patients with MAFLD},
journal = {Yearbook of Paediatric Endocrinology},
year = {2025},
doi = {10.1530/ey.22.15.2}
}
EUVIMED